Leocarpinolide F

CAS No. 145042-08-6

Leocarpinolide F( ——— )

Catalog No. M38384 CAS No. 145042-08-6

Leocarpinolide F is a natural sesquiterpenoid that can be isolated from Siegesbeckia orientalis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Leocarpinolide F
  • Note
    Research use only, not for human use.
  • Brief Description
    Leocarpinolide F is a natural sesquiterpenoid that can be isolated from Siegesbeckia orientalis.
  • Description
    Leocarpinolide F is a natural sesquiterpenoid that can be isolated from Siegesbeckia orientalis.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    145042-08-6
  • Formula Weight
    376.4
  • Molecular Formula
    C20H24O7
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ying Xiang, et al. Novel Sesquiterpenoids from Siegesbeckia orientalis. HELVETICA. Volume88, Issue1 January 2005. Pages 160-170.
molnova catalog
related products
  • Ganoderic acid X

    Ganoderic acid X is a potential Mdm2 inhibitor(K(i) = 16nM). It is a potential anticancer drug, inhibits topoisomerases and induces apoptosis of cancer cells.

  • 3-O-Acetyl-16 alpha-...

    3-O-Acetyl-16 alpha-hydroxytrametenolic acid has inhibitory activities against AAPH-induced hemolysis of red blood cells, it shows a strong inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice.

  • Dalbavancin Impurity

    Dalbavancin is a semisynthetic lipoglycopeptide that was designed to improve upon the natural glycopeptides currently available, vancomycin and teicoplanin.